U.S. pharma giant copyright scrapped two experimental weight loss products final yr—a at the time-every day pill, lotiglipron, on account of elevated liver enzymes plus a two times-each day capsule, danuglipron, resulting from robust side effects—but CEO Albert Bourla has said the company is set to “Engage in and win” within the being overw